Lung Cancer Considered

By IASLCScience

Lung Cancer Considered episodes

September 11, 2024 Live From WCLC 2024: Nurse Practitioner Highlights
In this special episode of Lung Cancer Considered, Stephanie McDonald and Jillian Thompson discuss their perspectives of attending the 2024 World Conference on Lung Cancer as nurse practitioners.
Hear their favorite sessions, their observations as first-time attendees, and why they hope to see more nurse practitioners at future IASLC events.
Guests:
Jillian Thompson, MSN, ANP-BC, AOCNP
Nurse Practitioner
MedStar Georgetown University Hospital
Lombardi Comprehensive Cancer Center
Stephanie McDonald RN, MSN, FNP-BC, AOCNP
Nurse Practitioner
Dana-Farber Cancer Institute
14 min
September 11, 2024 LCC in Spanish: WCLC 2024 Highlights
The 2024 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC’s 50th anniversary. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2024 in world languages.
In this episode, host Dr. Coral Olazagasti moderates a discussion in Spanish about highlights from the conference with Dr. Maria Velez and Dr. Rossana Ruiz.
Guests:
Dr. Coral Olazagasti
Assistant Professor at the Sylvester Cancer Center, University of Miami at Miami, Florida.
Dr. Rossana Ruiz
Medical Oncologist from Universidad Peruana Cayetano Heredia Global Health Fellowship at MGH in Boston, Massachusetts
Thoracic Medical Oncologist, Instituto Nacional de Enfermedades Neoplasicas and AUNA-Oncosalud in Lima, Peru
Dr. Maria Velez
Clinical Instructor, Division of Hematology-Oncology
UCLA David Geffen School of Medicine in Los Angeles, California
25 min
September 11, 2024 Live From WCLC 2024: Meeting Summary
In this special WCLC 2024 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu recap the conference and discuss the meeting's most impactful research.
Dr. Jacob Sands discusses overall survival updates from TROPION-Lung01 with datopotamab deruxtecan and DeLLphi-301 with tarlatamab. Dr. Hidehito Horinouchi reports results from the LUMINOSITY study of telisotuzumab vedotin, and Dr. Noemi Reguart gives some perspective on TRUST-II with talectrectinib. The group discusses the biggest stories from WCLC 2024, their favorite moments, and a preview of WCLC 2025 in Barcelona, Spain.
Guests:
Dr. Hidehito Horinouchi
Assistant Chief, Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo
General Secretary, Japan Clinical Oncology Group
Dr. Noemi Reguart
Clinical Professor at the University of Barcelona
Coordinator of the Thoracic Oncology Unit, Hospital Clínic Barcelona, Spain
WCLC 2025 Co-Chair
Dr. Jacob Sands
Assistant Professor of Medicine, Harvard Medical School
Lowe Cancer Center for Thoracic Oncology
Dana Farber Cancer Institute
41 min
September 10, 2024 LCC in Mandarin: WCLC 2024 Highlights
The 2024 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC’s 50th anniversary. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2024 in world languages.
In this episode, host Dr. Chunxia Su moderates a discussion in Mandarin about highlights from the conference with Dr. Huijuan Wang and Dr. Lin Wu.
Guests:
Dr. Chunxia Su
Professor of Oncology at Tongji University
Deputy Director of Medical Oncology at Shanghai Pulmonary Hospital
Dr. Huijuan Wang
Professor of Oncology Department of Medical Oncology
The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital
Dr. Lin Wu
Director, Thoracic Oncology Department II
Hunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University
27 min
September 09, 2024 Live From WCLC 2024: Monday Highlights
In this special WCLC 2024 episode of Lung Cancer Considered, host Dr. Narjust Florez discusses daily highlights from the conference.
Dr. Xiuning Le reports updated results of BAY 292708, and Dr. Gerrina Ruiter summarizes the Beamion LUNG-1 study, both of which evaluate the efficacy of therapies for patients with HER2-Mutant NSCLC. Dr. Fiona Hegi-Johnson adds her perspective as a discussant of the POLESTAR trial evaluating EGFR therapy after chemoradiation in stage III unresectable NSCLC.
Guests:
Dr. Fiona Hegi-Johnson
Radiation Oncologist at the Peter MacCallum Cancer Centre
Senior Research Fellow at the University of Melbourne
Dr. Xiuning Le, M.D., Ph.D.
Assistant Professor in the Department of Thoracic/Head and Neck Medical Oncology
University of Texas M.D. Anderson Cancer Center
Dr. Gerrina Ruiter, M.D., Ph.D.
Pulmonologist Specialized in Thoracic Oncology at the Netherlands Cancer Institute
Amsterdam, The Netherlands
38 min
September 09, 2024 LCC in Korean: WCLC 2024 Highlights
The 2024 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC’s 50th anniversary. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2024 in world languages.
In this episode, host Dr. Chul Kim moderates a discussion in Korean about highlights from the conference with Dr. Jeongmin Seo and Dr. Jii Bum (Joy) Lee.
Guests:
Dr. Chul Kim, MD
Associate Professor at Georgetown University with a focus on thoracic oncology
Dr. Jeongmin Seo, MD
Clinical Assistant Professor at Seoul National University Bundang Hospital with a focus on thoracic oncology
Dr. Jii Bum (Joy) Lee, MD, PhD
Yonsei Cancer Center, Yonsei University College of Medicine
26 min
September 08, 2024 Live From WCLC 2024: Sunday Highlights
In this special WCLC 2024 episode of Lung Cancer Considered, host Dr. Stephen Liu discusses daily highlights from the conference.
Dr. Caicun Zhou discusses the results of ivonescimab versus pembrolizumab in the first-line HARMONi-2 study. Dr. Tina Cascone discusses preliminary outcomes from the perioperative NeoCOAST-2 study, and Dr. Marina Chiara Garassino outlines the potential QCS-NMR TROP2 biomarker using data from TROPION-Lung01. Dr. Matthew Smeltzer shares the results of the 2024 IASLC Global Survey on Biomarker Testing and how they compare to findings from the previous survey in 2018.
Guests:
Dr. Tina Cascone
Physician-Scientist and Associate Professor, Department of Thoracic/Head and Neck Medical Oncology
University of Texas MD Anderson Cancer Center in Houston, Texas
Dr. Marina Chiara Garassino
Director, Thoracic Oncology Program and Professor of Medicine
University of Chicago
Dr. Matthew Smeltzer
Associate Professor, Division of Epidemiology, Biostatistics, and Environmental Health
University of Memphis
Professor Caicun Zhou
Chief Physician and Director of the Department of Medical Oncology
Tongji University in Shanghai Pulmonary Hospital
34 min
September 03, 2024 With Eyes On The Future IASLC 50th Anniversary
Description: To celebrate IASLC’s 50th Anniversary, IASLC produced podcasts looking at our past and present. In this podcast, host Dr. Narjust Florez peers into the future with a detailed discussion of the new IASLC Strategic Plan and how it will impact IASLC as well as the future of lung cancer care.
Guest: Dr. Nick Pavlakis is a thoracic medical oncologist and professor of medicine at the University of Sydney.
Guest: Dr. Gilberto Lopes is the Chief of the Division of Medical Oncology at Sylvester Comprehensive Cancer Center, Associate Director for the Cancer Center and Medical Director for International Affairs and Professor of Medicine at the University of Miami.
42 min
August 27, 2024 IASLC's 50th Anniversary: The IASLC Today
Description: This year marks the 50th anniversary of the International Association for the Study of Lung Cancer and as part of this celebratory year, we are looking at the past, present and future of the organization. In this episode of Lung Cancer Considered, host Dr. Stephen Liu and guests focus on IASLC today – and some of the ongoing efforts of the IASLC and its members.
Guest: Dr. Christian Rolfo, Professor of Medicine, Director of Medical Oncology and Associate Director for Early Phase Clinical Trials at the Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University.
Guest: Janet Freeman-Daily, Patient Research Advocate, Co-Founder and President of The ROS1ders, former Associate Editor of IASLC Lung Cancer News and co-developer of the IASLC STARS program.
Guest: Dr. Emily Stone is a Consultant Respiratory Physician at St. Vincent’s Hospital in Sydney Australia, conjoint Professor at the University of New South Wales, past Chair of the IASLC Tobacco Control and Smoking Cessation Committee, Deputy Chair Thoracic Oncology Group of Australasia and current Editor in Chief of the JTO Clinical and Research Reports
42 min
August 20, 2024 IASLC - The First Decade
In 1972, in response to the overwhelming need for collaboration and a growing concern for public health, Drs. David T. Carr, Oleg S. Selawry, Lawrence Broder, Clifton Mountain and George Higgins began building an international, multidisciplinary organization. In 1974, the group launched the International Association for the Study of Lung Cancer (IASLC) at their first formal meeting in Florence, Italy, having recruited more than 250 founding members from across the globe and with different perspectives. In today’s episode, host Dr. Narjust Florez talks with two of those early members who played influential roles in IASLC’s early growth and success: Dr. Paul Bunn and Dr. Fred Hirsch.
Guest: Dr. Paul Bunn is a Distinguished Professor of Medicine and James Dudley Chair in Cancer Research, Division of Medical Oncology at the University of Colorado School of Medicine. Dr Bunn was President of the ASCO and he served as president and as CEO, of the International Association for the Study of Lung Cancer.
Guest: Dr. Hirsch is the Executive Director at the Center for Thoracic Oncology in The Tisch Cancer Institute at Mount Sinai (TCI) and the Joe Lowe and Louis Price Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai. Dr. Hirsch served as Chief Executive Officer of IASLC for five years.
53 min

About Lung Cancer Considered

From the publisher's feed

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.